ALK-Abello UK and Ireland News and Activities
Presence
Headquarters: United Kingdom (UK)
ALK-Abello is a company listed under the stock ticker AKBLF (DK).
ALK-Abello has a direct presence in 5 countries.ALK-Abello has 4 subsidiaries including ALK-Abello Europe, ALK-Abello Germany and ALK-Abello North America.
Executives
View the org chart displaying its 6 main executives
Most searched biographies at ALK-Abello UK and Ireland
- Emil Stage Olsen, General Manager, United Kingdom and Ireland
- Lakshmi Nicholson, Associate Medical Director
- Wyn Roberts, Market Access Manager
Popular executive movements at ALK-Abello
- Edward Jordan will join the company as Executive Vice President and Head of Commercial Operations, North America on Jan. 5, 2026 (posted on December 2 2025).
- Soeren Niegel who was Executive Vice President, Commercial Operations, becomes Executive Vice President, Commercial Operations, North America (posted on September 8 2025).
- Jacob Glenting who was Senior Vice President, Global Strategy & Corporate Development, becomes Senior Vice President, Global Strategy, Corporate Development and Global Marketing (posted on September 8 2025).
Click here to view some more movements at ALK-Abello
Create your alert
to follow the executive moves at ALK-Abello UK and Ireland.
Pharmaceuticals
ALK-Abello has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Corden Pharma has announced the acquisition of AmbioPharm (posted on June 5 2026).
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
Popular contacts in Pharmaceuticals
News
Press releases by ALK-Abello UK and Ireland
Social media about ALK-Abello UK and Ireland
- ALK-Abello UK and Ireland on Wikipedia, Google News & Yahoo Finance
- ALK-Abello UK and Ireland on LinkedIn, X (Twitter) & YouTube
